Biopharma scientists are under pressure to accelerate development timelines for complex biologics and genomic medicines by closing the developability gap early to de-risk late-stage manufacturing failures. To do this, they rapidly need to gain deeper insight into molecule’s structural liabilities and their impact on its function.
Watch our specially curated series of on-demand webinars to discover technologies and workflows to help you accelerate the development pace of your next generation biotherapeutics.
Accelerating the characterization of next generation biotherapeutics with novel ion trapping and alternative fragmentation
Advanced technology to accelerate development of next-generation biotherapeutic
Transform your timelines: Cut development time through multi-capillary CE-SDS and cIEF analysis of mAbs and mAb variants
Comprehensive analysis of next generation biologics using advanced data interpretation software